Table 4.

Correlation of EBV-DNA detection in separate specimens (EBV+) with EBV seroprevalence in healthy controls.

	Correlations in healthy controls
	IgG	IgM	Serum	PBMCs	Saliva
EBV-IgG (U/mL)
Pearson correlation	1	.457	.300	.570**	.562**
Sig. (2-tailed)		.543	.199	.000	.000
EBV-IgM (U/mL)
Pearson correlation	.457	1	−.083	−.940	−.343
Sig. (2-tailed)	.543		.917	.060	.572
Serum DNA (copies/mL)
Pearson correlation	.300	−.083	1	.216	.549**
Sig. (2-tailed)	.199	.917		.346	.012
PBMCs DNA (copies/mL)
Pearson correlation	.570**	−.940	.216	1	.617**
Sig. (2-tailed)	.000	.060	.346		.000
Saliva DNA (copies/mL)
Pearson correlation	.562**	−.343	.549*	.617**	1
Sig. (2-tailed)	.000	.572	.012	.000

^*Correlation is significant at the 0.05 level (2-tailed).

^**Correlation is significant at the 0.01 level (2-tailed).